Popeye domain-containing 1 is down-regulated in failing human hearts

Rachel Gingold-Belfer1, Michael Bergman, Yifat Alcalay

  • 1Basil and Gerald Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel-Aviv University, Petach-Tikva 49100, Israel.

Insights

Congestive heart failure alters Popeye domain-containing (POPDC) gene expression in human hearts. POPDC1 levels decrease, particularly in the left ventricle, suggesting its susceptibility to heart failure.

Area of Science:

  • Cardiovascular Biology
  • Molecular Genetics
  • Gene Expression Regulation

Background:

  • Congestive heart failure (CHF) involves complex genetic alterations.
  • The Popeye domain-containing (POPDC) gene family (POPDC1-3) is muscle-restricted and developmentally regulated.
  • POPDC1's role in stressed mouse muscle is known, but its function in human hearts is unexplored.

Purpose of the Study:

  • To investigate the cellular distribution and expression of POPDC1 in human hearts.
  • To analyze the expression patterns of POPDC1-3 mRNAs in non-failing and failing human hearts.
  • To determine the impact of heart failure on POPDC gene expression.

Main Methods:

  • Immunohistochemistry and Western immunoblotting for POPDC1 protein.
  • Reverse transcription/quantitative polymerase chain reaction for POPDC1-3 and MYHC7 mRNA levels.
  • Analysis of human heart biopsies from non-failing and failing individuals.

Main Results:

  • POPDC1 localized to the sarcolemma, enhanced at intercalated discs, with deranged labeling in failing hearts.
  • All three POPDC mRNAs expressed in all four chambers, higher in ventricles.
  • Heart failure correlated with reduced POPDC1 mRNA and protein in the left ventricle.
  • Coordinated regulation observed between POPDC1/POPDC3 and POPDC2/MYHC7 mRNA levels.

Conclusions:

  • POPDC gene expression is significantly modified in end-stage human heart failure.
  • Evidence suggests differential regulation and function among POPDC family members.
  • POPDC1 appears particularly susceptible to the pathological changes in heart failure.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...